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AbstrAct
Objectives Exposing children to secondhand tobac-
co smoke (SHS) causes signiicant harm and occurs 
predominantly through smoking by caregivers in the 
family home. We report a trial of a complex intervention 
designed to reduce secondhand smoke exposure of chil-
dren whose primary caregiver feels unable or unwilling 
to quit smoking.
Design An open-label, parallel, randomised controlled 
trial.
setting Deprived communities in Nottingham City and 
County, England
Participants Caregivers resident in Nottingham City 
and County in England who were at least 18 years old, 
the main caregiver of a child aged under 5 years living 
in their household, and reported that they were smoking 
tobacco inside their home.
Interventions We compared a complex intervention 
combining personalised feedback on home air quality, 
behavioural support and nicotine replacement therapy 
for temporary abstinence with usual care.
Main outcomes The primary outcome was change in 
air quality in the home, measured as average 16–
24 hours levels of particulate matter of <2.5 µm diameter 
(PM
2.5
), between baseline and 12 weeks. Secondary 
outcomes included changes in maximum PM
2.5
, 
proportion of time PM
2.5
 exceeded WHO recommended 
levels of maximum exposure of 25 µg/mg3, child salivary 
cotinine, caregivers’ cigarette consumption, nicotine 
dependence, determination to stop smoking, quit 
attempts and quitting altogether during the intervention.
results Geometric mean PM
2.5
 decreased signiicantly 
more (by 35.2%; 95% CI 12.7% to 51.9%) in 
intervention than in usual care households, as did the 
proportion of time PM
2.5
 exceeded 25 µg/mg3, child 
salivary cotinine concentrations, caregivers’ cigarette 
consumption in the home, nicotine dependence, 
determination to quit and likelihood of having made a 
quit attempt.
conclusions By reducing exposure to SHS in the homes 
of children who live with smokers unable or unwilling 
to quit, this intervention offers huge potential to reduce 
children’s’ tobacco-related harm.
trial registration number ISRCTN81701383. This 
trial was funded by the UK National Institute for Health 
Research (NIHR): RP-PG-0608-10020 
IntrODuctIOn
The detrimental health effects of exposing chil-
dren to secondhand tobacco smoke (SHS) are well 
established and include increased risks of lower 
respiratory infections,1 wheeze and asthma,2 middle 
ear disease,3 meningitis4 and sudden infant death 
syndrome.5 6 Most childhood SHS exposure occurs 
in the home environment,5 6 with 39% of English 
children who live with smokers exposed in the 
home on a regular basis.7 Notably, the highest levels 
of SHS exposure is found in the most socioeconom-
ically disadvantaged families, where caregivers are 
more likely to be smokers and to smoke heavily,8 9 
thus reinforcing the gradient of health inequalities 
through intergenerational perpetuation of tobacco 
dependence and harm.10
Although the optimal means of eliminating 
childrens exposure to SHS in the home is for 
caregivers to quit smoking, it is apparent that 
this cannot always be successfully or sustainably 
achieved.11 Where quitting smoking is not desired 
by or not achievable for caregivers, a next best 
option to reduce childrens exposure is to support 
caregivers in making their homes completely 
smoke free.11 A range of approaches based on 
behaviour change theories and educational strate-
gies has been proposed to help to protect children 
from exposure to SHS and to promote smoke-free 
homes (SFHs) for children.12 However, a review 
of interventions aimed at promoting SFHs,13 and 
a systematic review14 and separate meta-analysis15 
of interventions aimed at reducing childrens expo-
sure to SHS have found mixed evidence for effec-
tiveness that was insufficient to recommend any 
one specific interventional strategy over another. 
A more recent systematic review16 and meta-anal-
ysis highlighted that measuring the effectiveness of 
SHS interventions can be problematic. It concluded 
that, although some studies that had used objec-
tive measures of SHS exposure had shown to be 
effective in reducing exposure to SHS in the home, 
air contamination through SHS was still overall 
significant following the intervention in the study 
homes. The authors further acknowledged that it 
is important that further effective interventions to 
promote SFHs are developed.16
On the basis of a UK feasibility study, which 
showed that providing families with personalised 
home air quality feedback combined with a moti-
vational interviewing approach had potential to 
improve home air quality,17 and findings from our 
own development work,18 19 we designed a complex 
intervention comprising behavioural and pharma-
cological support including personalised indoor air 
quality feedback. We hypothesised that air quality 
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and other markers of SHS exposure (eg, saliva cotinine) and 
smoking behaviour (eg, numbers of cigarettes smoked in the 
home per day) in homes receiving the complex intervention 
would be significantly decreased compared with homes that did 
not. We now report results from a randomised controlled trial 
assessing the effectiveness of this intervention in reducing chil-
drens exposure to SHS in the home.
MethODs
trial design
We conducted an open-label, parallel, randomised controlled 
trial in deprived communities in Nottingham City and County 
in England. Ethical approval for the trial was granted by the 
National Research Ethics Service West Midlands, Solihull, in 
September 2012.
PArtIcIPAnts
We recruited and followed up caregivers resident in Nottingham 
City and County in England who were eligible to participate if 
they were at least 18 years old, were the main caregiver of a 
child aged under 5 years living in their household (in house-
holds with more than one child under 5 years, the youngest was 
defined as index child for the study) and reported that they 
were smoking tobacco inside their home. Potential participants 
who were already trying to quit smoking or had attempted to do 
so in the 3 months preceding recruitment were excluded, as were 
pregnant smokers, those planning a pregnancy or breast feeding 
during the intervention period, those with health-based contra-
indications to nicotine replacement therapy (NRT) use and those 
living in hostels or refuges.
Participants were recruited from 81 English Sure Start 
Childrens Centres across Nottinghamshire, which offer free 
services for disadvantaged families with children up to 5 years 
of age, designed to improve health, language and readiness to 
learn before school.20 Potential participants were identified and 
approached with the help of Childrens Centre managers and 
through attendance of outreach activities such as play sessions. 
The research team also liaised with community-based Health 
Visitors (registered nurses who offer health advice and support 
to families with preschool children) in deprived areas. An invi-
tation to take part was mailed from a large inner city general 
practice to all eligible caregivers. Participants received an incon-
venience allowance of £50 high street shopping voucher on 
completion of data collection.
randomisation and masking
After obtaining written informed consent, caregivers (and their 
households) were randomised either to the complex interven-
tion or to usual care in a 1:1 ratio based on a computer-gen-
erated pseudo-random code using random permuted blocks of 
randomly varying size created by the Nottingham Clinical Trials 
Unit. The trial necessarily used an open design, but analysis was 
carried out blind to treatment group.
PrOceDures
Data collection
In both treatment groups, data were collected during home visits 
at baseline, 7 and 12 weeks, carried out by a researcher and a 
smoke-free homes advisor (SFHA), trained according to the UK 
National Centre for Smoking Cessation and Training Level one 
standard. Participants completed questionnaires on socioeco-
nomic status, their own and the index childs health, family and 
household composition, current smoking behaviour and beliefs 
relating to home smoking with children . Indoor air was sampled 
for up to 24 hours using a Sidepak Aerosol Monitor AM510 (TSI 
Instruments Ltd, High Wycombe, UK), positioned in the main 
living area. Monitors were set with the calibration factor of 0.30 
by the manufacturer to measure particle sizes of secondhand 
smoke.21 PM
2.5
 data were logged at 60 s intervals throughout the 
data collection period, which varied between 16 and 24 hours, 
depending on when a collection of the monitor could be 
arranged with participants. Two air monitors were affected by 
calibration error, resulting in their calibration factor being set to 
1.0 for a period of time throughout the study. Affected data were 
converted to the correct calibration level retrospectively using 
Trackpro software in a standard approach, and participants were 
notified. Saliva samples to measure cotinine, the major prox-
imate metabolite of nicotine and a biological marker for SHS 
exposure16 22 were taken from the index study child during the 
home visit by a member of the research team in the presence of 
the caregiver, using appropriate swabs (Salimetrics infant swabs). 
Samples were analysed in a quantitative assay using liquid chro-
matography tandem mass spectrometry (ABS Laboratories).
Intervention
The intervention comprised feedback on the air quality measured 
in the home; behavioural support on how to create an SFH deliv-
ered by a specialist SFHA; and NRT for temporary abstinence 
or for cutting down tobacco smoking in the home, provided at 
baseline, 7 and 12 weeks.
Air quality measurement and personalised feedback
Using Trackpro software installed on the air monitors, the 
research team converted data collected during the three periods 
of air quality measurement (baseline, week 7 and week 12) into a 
graphical format that could be easily explained to the participant 
immediately after each measurement period, relating the infor-
mation to the WHO recommended 24 hours of PM
2.5
 concen-
trations below 25 µg/m3 per 24-hour period.23 Participants were 
shown the graphs with attention drawn to periods of time that 
showed particularly high or low SHS exposure in the home, 
supported by the discussion of reasons for high or low values 
and of strategies to reduce exposure both in general and during 
periods when levels were particularly high. Data collected at 
weeks 7 and 12 were super imposed on the baseline graph to 
enable the comparison of PM
2.5
 levels over the intervention 
period.
Behavioural support from specialist smoke-free home advisors
Behavioural support for the intervention group comprised 
face-to-face home visits by a specialist SFHA offered on four 
occasions (12 days after baseline measurements, at 3, 7 and 
12 weeks) and lasting for up to 1 hour. The SFHA and partic-
ipants discussed current smoking behaviours in and around 
the home using a Smokefree Home Factsheet for reference 
(see online supplementary appendix 1), and explored person-
alised strategies to avoid smoking indoors in the context of indi-
vidual circumstances, the availability of outdoor spaces and the 
need for constant supervision of children. In addition, partici-
pants received a minimum of two proactive phone calls (during 
the second week and after 5 weeks of follow-up) and the offer 
to contact the SFHA via phone or text message on an ad hoc 
basis for support during the intervention period during office 
hours, if required. Adult smokers living in the same household 
were eligible to receive the same behavioural and pharmacolog-
ical support.
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Nicotine Replacement Therapy
Nicotine replacement therapy (NRT) products licensed for 
temporary abstinence and cutting down on smoking, including 
mouth spray, nicotine gum, lozenges, inhalers and patches, were 
offered to all participants free of charge and dispensed by the 
SFHA. Participants were provided with samples of small quan-
tities of the NRT products to support an informed choice on 
which one (or which combination) may be best suited to them. 
Suitability and use were reviewed during the 12 weeks proac-
tive phone call and at each home visit and a further 4 or 5 
weeks of product dispensed at the 3-week and 7-week visits, if 
appropriate. Thus, a maximum of 12 weeks of free NRT was 
dispensed.
Participants who expressed an interest in quitting smoking 
altogether were advised that NRT products could be used for 
this purpose and received advice on a quitting strategy, or where 
interest was expressed at the 12-week appointment, a referral to 
the local specialist stop smoking services.
usual care
Participants randomised to the usual care group were provided 
with a Smoke Free Homes resource pack, developed by the 
local Stop Smoking Service (SSS) as standard support routinely 
offered to caregivers with young children who smoked at the 
time the study was designed. The pack contained a fact sheet, 
booklet, door hangers, magnets, stickers, information on 
constituents of tobacco smoke and how to keep the family and 
home safe, and local stop smoking service contact informa-
tion (see online supplementary appendix 1). On completion of 
the study at week 12, all participants in the usual care group 
received graphical feedback on their home air quality data and 
basic behavioural advice supported by the offer of 1 months 
supply of free NRT products for temporary abstinence and/or 
cutting down dispensed by the SFHA. During the course of the 
study, the usual care resource pack offered by the local SSS was 
discontinued as standard care. As per protocol, it was, however, 
continued to be used for the purpose of this study.
OutcOMes
The primary outcome was the change in average home air 
quality (indoor 1624 hour average PM
2.5
) between the base-
line and 12-week measurement, compared between treatment 
groups, based on the rationale that, in contrast to other measures 
(such as saliva cotinine), this measure relates specifically to the 
intervention rather than secondhand smoke exposure in more 
general terms. Secondary outcome measures, also compared 
between treatment groups, included maximum concentrations 
of PM
2.5
, the proportion of time PM
2.5
 concentrations exceeded 
WHO recommended levels of maximum exposure of 25 µg/m3 
per 24 hours period,23 salivary cotinine levels in the index child, 
caregiver-reported cigarette consumption in the home, care-
givers Heaviness of Smoking Index (HSI),24; determination to 
quit, quit attempts and quitting altogether.
stAtIstIcAl AnAlysIs
An intention-to-treat analysis was performed using all randomised 
participants. Data on air quality were considered sufficient for 
analysis where 16 hours or more of particulate matter measure-
ments had been obtained. The sample size was defined as 100 
participating households per group, powered at 83% assuming 
alpha 0.05 and calculated to detect a 33% reduction between 
baseline and week 12 in log-transformed mean home air quality 
(PM
2.5
) in the intervention group compared with the usual care 
group.16
The primary outcome was compared between intervention 
and control groups using multiple linear regression, adjusted for 
baseline (basic model), and then adjusted for season, partners 
smoking status and multiple deprivation index as prognostic 
variables (adjusted model). Our primary analysis used a multiple 
imputation model, assuming that those participants who refused 
consent for follow-up were missing at random and included all 
relevant variables to predict average PM
2.5
 in the model (HSI, 
number of cigarettes smoked daily inside the house, demographic 
characteristics and the outcome measure). We carried out a 
range of sensitivity analyses using alternative assumptions about 
the missing data (complete case and last observation carried 
forward), using specific models for data over repeated measures 
(mixed model), excluding those participants with affected air 
quality readings due to calibration error, and using alterna-
tive definitions for our primary outcome variable. Alternative 
assumptions about missing data included a complete case model 
that assumes missing completely at random and a last observation 
carried forward model, assuming those lost to follow-up would 
have preserved similar air quality levels from the last observation 
recorded. Second, to account for repeated measures from the 
same units, we used a mixed methods approach incorporating all 
three repeated measurements with a random effect to allow for 
clustering by household. Third, to explore the impact of calibra-
tion factor errors, we performed the primary analysis excluding 
those participants affected by incorrect air quality readings and, 
finally, we used two alternative computations of mean PM
2.5
 
including only those participants with paired measurements 
at baseline and week 12 obtained at exactly the same time of 
day for the household and across all households. For secondary 
outcomes, a complete case approach was used, with linear regres-
sion for continuous variableslog-transformed when appro-
priateand logistic regression for categorical variables.
PArtIcIPAnt InvOlveMent
A lay representative was a coapplicant on the original research 
proposal and was involved in the early stages of study design. We 
carried out extensive qualitative and feasibility work with fami-
lies prior to conducting the trial to ensure that their opinions and 
experiences informed both the intervention components and the 
outcome measures accordingly. Findings will be disseminated via 
the Public and Patient Involvement (PPI) group established in the 
context of the larger programme of research related to this trial. 
No further PPI involvement took place.
results
We assessed a total of 7861 caregivers, 1495 of whom were 
smokers with an interest in study participation. Of these, 297 
fulfilled our eligibility criteria and 205 were randomised: 103 to 
intervention and 102 to usual care (figure 1), between October 
2012 and September 2015. Baseline demographic and smok-
ing-related data are shown in table 1. On average, participants 
multiple index of deprivation25 indicated high levels of social 
disadvantage (within the lowest quintile of the national range), 
and the majority lived in homes owned by the local authority. 
The number of cigarettes consumed inside the home per day 
was reported to be approximately 15, with the HSI indicating 
moderate levels of caregivers tobacco dependence. In both 
groups, the majority of caregivers declared not having a partner 
who cohabited with them all the time and had two children on 
average living in their household.
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The primary analysis by multiple imputation showed a significant 
(p<0.001) reduction in 1624 hours average PM
2.5
 at 12 weeks 
in the intervention group compared with the usual care group, 
adjusted for baseline and additionally for other prognostic factors 
(see Table 2, supplementary table1). Very similar results were 
obtained in the sensitivity analyses. The multiple imputation coef-
ILFLHQWRIï SGHQRWHVZKHQXQORJJHG DGHFUHDVH
of air pollution in the intervention group of 36.3%. Taking into 
Figure 1 Approach, assessment for eligibility, randomisation and follow-up.
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account this reduction and the skewedness of the primary outcome, 
a participant in the median of the distribution, with a 1624 hour 
average PM
2.5
 of 28.3 µg/m3 would have a concentration of 18.3 µg/
m3 of PM
2.5
 by the end of week 12, which is below WHO-rec-
ommended safe levels of indoor 24 hours PM
2.5
 concentration.23 
Figure 2 depicts predicted log-transformed 1624 hours average 
PM
2.5
 from the mixed model for participants in the intervention 
and usual care groups. The model estimated a difference between 
JURXSVDWZHHNRIï&,ïWRïHTXDWLQJWR
a decrease of 35.2% (95% CI 12.7% to 51.9%).
Analysis of secondary outcomes (see Table 3, supplementary table 
2) showed that the proportion of time spent above 25 µg/m3 in the 
home and salivary cotinine from the index child, valid and compa-
rable for 47.1% of the sample, had decreased in the intervention 
compared with the usual care group, although the latter was statisti-
cally significant only in the adjusted analysis (p=0.04). The number 
of cigarettes smoked in the home and HSI were both reduced signifi-
cantly in the intervention compared with the usual care group both 
in basic and adjusted analysis. There was a threefold increase in the 
odds of making an attempt to quit during the 12 weeks of the study 
in the intervention group compared with usual care, whereas the 
proportion of those who had quit altogether was not significantly 
different between groups, and determination to quit was higher in 
the usual care group at 12 weeks. No important unintended harms 
resulted from the intervention in either group.
The vast majority of participants in the intervention group had 
received air quality feedback and behavioural support at baseline, 
week 7 and week 12; approximately two-thirds were using NRT 
products at week 12. Table 2 details the information related to 
adherence to the intervention and participants perception of 
importance of single intervention components received.
DIscussIOn
In this randomised controlled trial, a complex intervention 
combining personalised feedback on home air quality with 
behavioural and pharmacological support achieved significant 
behaviour change, improvements in indoor air quality and conse-
quent reductions in exposure of young children to SHS as measured 
by salivary cotinine. Notably, these changes took place in predom-
inantly highly disadvantaged single-parent families who, at the 
outset of the study, were not willing to consider quitting smoking. 
To our knowledge, this is the first trial to demonstrate effective-
ness of this type of intervention across a comprehensive range of 
primary and secondary outcome measures, including home air 
quality, child salivary cotinine, smoking and quitting behaviour. 
It demonstrates that an intensive intervention can succeed in 
preventing harm to children from SHS even in the most difficult 
circumstances, with the potential to break the intergenerational 
table 2 Adherence to intervention components and importance 
ranking at week 12 for the intervention group (number and percentage 
in brackets)
baseline  
(%)
Week 7  
(%)
Week 12  
(%)
Intervention group study participants 102 (100) 95 (93) 95 (93)
Received valid air quality feedback 101 (99) 94 (92) 91 (89)
Received behavioural support 102 (100) 95 (93) 95 (93)
Used any NRT during the study* – 73 (79) 64 (67)
Used inhalator – 39 (42) 31 (33)
Used gum – 36 (39) 24 (26)
Used lozenge – 22 (24) 16 (17)
Used patch – 15 (16) 13 (14)
Used quick mist – 22 (24) 16 (17)
Used other – 2 (2) 1 (1)
Ranking of intervention components
Ranked air quality feedback irst – – 65 (68)
Ranked behavioural support irst – – 13 (14)
Ranked NRT irst – – 17 (18)
Ranked air quality feedback second – – 21 (22)
Ranked behavioural support second – – 49 (52)
Ranked NRT second – – 24 (26)
Ranked air quality feedback third – – 10 (11)
Ranked behavioural support third – – 31 (33)
Ranked NRT third – – 53 (56)
*Considers the use of NRT after irst advice from smoke-free homes advisors.
NRT, nicotine replacement therapy.
table 1 Baseline characteristics of the study participants by 
treatment group*
Intervention
(n=103)
usual care
(n=102)
Socioeconomic status
  Multiple Deprivation Index rank† 6569.7 (5432.5) 6643.1 (5679.0)
Housing tenure
  Own/mortgaged 6 (6%) 9 (9%)
  Private rent 48 (47%) 37 (36%)
  Council/local authority 47 (46%) 53 (52%)
  Other 2 (2%) 3 (3%)
  Adults, n 1.5 (0.6) 1.6 (0.7)
  Children, n 2.1 (1.2) 2.2 (1.2)
  Age of children, years 3.6 (2.6) 3.3 (2.3)
Cigarettes smoked daily inside the home, n
  Mean (SD) 15.0 (11.0) 15.0 (11.0)
  Median (IQR) 12.0 (8.0–20.0) 12.0 (7.0–20.0)
  Caregiver Heaviness of Smoking Index‡ 2.6 (1.5) 2.5 (1.6)
Seasonality at baseline appointment
  Warm 56 (54%) 53 (52%)
  Cold 47 (46%) 49 (48%)
Ethnicity
  Other 8 (8%) 4 (4%)
  White British 95 (92%) 98 (96%)
Partner cohabits all of the time
  Other 60 (58%) 58 (57%)
  Yes 43 (42%) 44 (43%)
  Age of caregiver, years 28.1 (6.2) 27.9 (6.6)
Air quality at home (PM
2.5
), µm/m3§
  Mean (SD) 54.6 (71.1) 46.5 (52.8)
  Median (IQR) 33.4 (12.3–77.8) 30.5 (14.1–72.7)
  Maximum PM
2.5
437.5 (590.6) 401.7 (433.6)
Cotinine index child, ng/mL
  Mean (SD) 7.5 (8.1) 7.6 (8.0)
  Median (IQR) 4.76 (6.21) 4.77 (7.48)
*Means and SD for most variables, unless otherwise stated. There was no 
statistically signiicant difference between groups in any of the variables listed.
†The Index of Multiple Deprivation rank goes from 1 (most deprived area) to 32 844 
(least deprived area).
‡Heaviness of Smoking Index derives from Fagerström Test for Nicotine Dependence 
but uses only two questions (how soon after waking up do you smoke your irst 
cigarette and how many cigarettes a day do you smoke). Scores range from 1 to 
6, where higher scores are for higher dependency and lower scores are for lower 
dependency.
§Indoor air pollution concentration, 24 hours average PM
2.5
 (21), and in our case, 
16–24 hours average PM
2.5
 is measured in µm/m3, which refers to milligrams of 
pollutant per cubic metre of air (in this case the pollutant is PM
2.5
).
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cycle of tobacco addiction and smoking-related harm. Although 
we did not investigate measures relating to the potential clinical 
effectiveness of reduced secondhand smoke exposure in the home 
on respiratory and other smoking-related conditions, our findings 
could be of particular relevance, in view of discussions relating to 
smoke-free public housing9 and the circumstance that recent trials 
of minimal interventions to achieve reduced secondhand smoke 
exposure have shown to be unsuccessful.26
Although all of the families enrolled in our trial belonged to 
low socioeconomic strata, and almost all were of white British 
background, our findings are likely to be generalisable to families 
of other socioeconomic or ethnic backgrounds with the shared 
common feature of a caregiver who feels unable or unwilling to 
quit smoking. However, in view of previous findings indicating 
that barriers to creating SFHs are particularly great among disad-
vantaged families,8 our results are of particular relevance and may 
have underestimated the effect the intervention could have in less 
challenging environments. Our findings do not appear to have been 
adversely affected by the calibration error that generated inflated 
home air quality measurements at baseline and/or at week 7 for 
29 participants, which was corrected for analysis of indoor air 
quality but resulted in the delivery of behavioural advice to these 
participants based on inflated readings. Although this may have 
affected motivation and behaviour change positively or negatively, 
depending on the context provided by previous measurements, our 
sensitivity analysis demonstrates that the error had little effect on 
key study outcomes.
In terms of the primary outcome (change in indoor air quality 
at 12 weeks), it is of note that particulate matter was sampled at 
various points using air monitors over a period of up to 24 hours. It 
is perceivable, particularly given the presence of the monitor inside 
the home, that participants could have adjusted their smoking 
behaviour to affect air quality readings. Although this is a possi-
bility that we cannot rule out, it is important to consider that we 
collected a number of other outcome measures, including salivary 
cotinine from the index children, that are less likely to be affected 
by short-term behaviour change or other bias. Results from our 
analysis of salivary cotinine measures were also significant, under-
pinning the likelihood of our findings related to indoor air quality 
being reliable. PM
2.5
 is an indirect but well-established measure of 
secondhand smoke and has been used extensively to assess second-
hand smoke levels in homes, and elsewhere.27 It can be affected 
by non-tobacco sources, including cooking, heating and environ-
mental exposures,27 but because our study was randomised and 
there is no reason to suspect that any change over time from other 
sources would affect the intervention group differentially from 
control, it is unlikely that this has affected our results.
The results of this study build on the Reducing Families' Expo-
sure to Secondhand Smoke in the Home (REFRESH) feasibility 
study, which only showed evidence of effectiveness within and not 
between treatment groups,17 suggesting that the more intensive and 
longer intervention period is important to support the initiation and 
maintenance of SFH to protect children from exposure to SHS. The 
reduction in levels of SHS exposure found in our study of caregivers 
who were unable or unwilling to quit smoking is similar to that 
reported in the American KISS Trial,28 which, however, included 
caregivers who had recently quit or tried to do so. This could be 
interpreted as evidence that our intervention was particularly 
effective because our population may have been less amenable to 
smoking-related behaviour change. Our findings also demonstrate 
intervention effectiveness across a range of further smoking-related 
measures, such as increases in determination to quit, and actual quit 
attempts, which predict further quit attempts in the future.29
This is in contrast to a US trial assessing a multicomponent 
intervention including motivational interviewing, where effective-
ness was found for improvement of air quality in the home only 
at 12-month follow-up but not before and not at all for salivary 
cotinine.30 It is possible that our intervention was more effective, 
because it was delivered in private family homes rather than largely 
in a public school environment, included NRT and personalised 
advice from trained smoke-free homes advisors to make the family 
home smokefree, thus being particularly tailored to individual need. 
In contrast also to a recently published RCT of a complex inter-
vention very similar to the one used in our study, conducted with 
205 families in Armenia31 using childrens hair cotinine as primary 
outcome measure, our findings of changes in salivary cotinine were 
significant in the adjusted analysis, although similar challenges in 
collecting samples for cotinine analysis from index children were 
Figure 2 Predicted 16–24 hours average PM
2.5
 (log transformed) and 95% CIs by group and follow-up from the mixed model.
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experienced. There was evidence in our study that determination 
to quit smoking was greater in participants who had received the 
low-intensity usual care intervention, which could be interpreted in 
various ways. For example, it could indicate satisfaction of complex 
intervention participants with their achievements and improved 
home air quality for their children, removing the perceived neces-
sity to stop smoking completely. However, the significantly higher 
number of quit attempts during the study in the intervention group, 
measured at various time points, contradicts this theory.
Overall, our intervention specifically contributes to the growing 
evidence base of effective multicomponent interventions that 
result in a reduction in PM
2.5
, which helps to protect children from 
exposure to SHS in the home.16 In addition, it helps to provide 
important information on intervention components and modalities 
that can be used to inform future meta-analyses/evidence syntheses 
given that, to date, systematic review evidence13 14 16 has not been 
able to recommend one specific intervention over another. It is 
important to notice that, as with other studies,16 our intervention 
did not eliminate SHS exposure in the participating homes. The 
need to develop and test complex interventions that have the 
potential to do so remains apparent.
The high retention of participants in our study can be 
viewed as a strength and as an indicator of high motivation 
among smokers to protect their children from SHS exposure, 
denoting the potential of widespread uptake of interventions 
to support this aim. The combination of a financial incentive 
on completion of data collection, free NRT, frequent commu-
nication with SFHAs and flexibility to accommodate partic-
ipants needs in terms of appointments is also likely to have 
contributed to the high retention.
An important consideration refers to the cost-effectiveness of 
the complex intervention tested here. An economic analysis is 
currently ongoing and will be made available elsewhere. Further 
research to refine our intervention, adapting it for widespread 
and sustainable application and taking into account participants 
perceived importance of intervention components is required. 
Rankings of importance obtained from our intervention partici-
pants indicate the central role of personalised air quality feedback 
(ranked as the single most important intervention component by 
most participants); further exploration of this and implications 
for future service development and implementation is warranted. 
Furthermore, research related to clinical impacts of reduction in 
SHS exposure is also required.
What this paper adds
 Ź Children’s exposure to secondhand tobacco smoke (SHS) is 
extremely harmful to health and occurs mainly in the home. 
Behavioural and pharmacological interventions can  
improve air quality in the homes of smoking caregivers  
motivated to quit smoking, thus reducing children’s harmful 
exposure to secondhand smoke in the home.
 Ź A complex intervention including behavioural and phar-
macological support and air quality feedback was effective 
in reducing children’s exposure to SHS in the homes of 
caregivers who were not motivated to quit in deprived 
communities and improved a range of smoking-related 
outcome measures, including saliva cotinine, daily cigarette 
consumption and quit attempts. It highlights the potential 
of such interventions to break the intergenerational cycle of 
tobacco-related harm even under the most dificult circum-
stances.
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